01345 SH PIONEER HLDG
- 2.010
- -0.040-1.95%
SH PIONEER HLDG News
SH Pioneer Holdings (01345) will distribute an interim dividend of HKD 0.048 per share on November 15th.
sh pioneer hldg (01345) announced that it will distribute dividends up to June 2024 on November 15, 2024...
Shanghai Pioneer Holdings (01345) announced its interim performance, with a net profit attributable to owners of 94.955 million yuan, a year-on-year increase of 23.32%.
Sh Pioneer Hldg (01345) announced its mid-year performance for 2024, with a profit of 0.818 billion yuan, a year-on-year increase...
Express News | Shanghai Pioneer Holding H1 Revenue RMB 427.6 Million
Express News | Shanghai Pioneer Holding H1 Basic EPS RMB 0.08
Express News | Shanghai Pioneer Holding H1 Gross Margin 42.8%
Express News | Shanghai Pioneer Holding H1 Net Income RMB 87.9 Million
Express News | Shanghai Pioneer Holding H1 Gross Profit RMB 350.5 Million
SH PIONEER HLDG: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2024
sh pioneer hldg (01345.HK) held a board of directors meeting on August 28 to approve its mid-year performance.
Sh Pioneer Hldg (01345.HK) announced that the board of directors will hold a meeting on Wednesday, August 28, 2024 to review the mid-term performance of the company and its subsidiaries for the six months ended June 30, 2024, and consider the payment of interim dividends (if any).
SH PIONEER HLDG: NOTICE OF BOARD MEETING
Guotou Securities: The market share of listed pharmacies continues to increase, and the growth potential is expected to lead the industry.
In the context of a slowdown in the industry's growth rate, listed pharmacies are expected to achieve growth rates higher than the industry by virtue of their continuous rapid expansion of stores.
Shanghai Pioneer Unit to Get 9 Million Yuan Cash Funding in Exchange for Shares, Product Sale Rights
Sh Pioneer Hldg (01345.HK) subsidiary Chongqing Qiushan receives 9 million yuan in cash financing.
Shanghai Pioneer Holdings (01345.HK) announced on July 29 that Chongqing QiuShan Medical Instruments Co., Ltd., a subsidiary of the company, has obtained RMB 9 million in cash financing from Guoyao Shengkang Hunan Pharmaceutical Co., Ltd. ("Guoyao Shengkang Hunan"). After all the payments are made, Guoyao Shengkang Hunan will obtain a certain proportion of shares of Chongqing QiuShan and obtain the exclusive agency sales rights of Q3 medical series innovative medical products in Hunan province, China. Guoyao Shengkang Hunan is located in Hunan Province, China, and is a company focused on prescription drugs and medical device consumption.
Express News | Shanghai Pioneer - Unit Obtained Cash Financing of RMB9 Mln From Guoyao Shengkang Hunan Pharmaceutical Co.
Express News | Shanghai Pioneer Holding Ltd -Acquisition of Cash Financing by Subsidiary
SH PIONEER HLDG: POLL RESULTS OF THE ANNUAL GENERAL MEETINGHELD ON 24 MAY 2024
SH PIONEER HLDG: Annual Report 2023
Shanghai Pioneer to Hire New Auditor
Shanghai Pioneer Holdings (01345.HK) plans to appoint Lixin as auditor
On April 24, Ge Longhui | Shanghai Pioneer Holdings (01345.HK) announced that Deloitte Guanhuang Chen Fang Certified Public Accountants (“Deloitte”) will retire as the company's auditor at the end of the company's recent annual general meeting after the end of its current term of office. Following Deloitte's retirement, Hong Kong Lixin Dehao Certified Public Accountants Limited (“Lixin”) was appointed as the company's new auditor, subject to shareholders' approval at the annual shareholders' meeting (Lixin will complete its internal client acceptance procedures prior to the annual shareholders' meeting).
Shanghai Pioneer Holding Ltd (HKG:1345) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable
Analysis
Price Target
No Data
No Data